TG Therapeutics Q3 Earnings Preview: Revenue Estimate Reported
TG Therapeutics is scheduled to report Q3 results on November 09. Revenue is estimated at 245.47 million USD and EPS at 0.37 USD; results are expected at 7:00 AM ET (12:00 PM UTC).
TGTX (TG Therapeutics, Inc.) is set to announce its Q3'26 results on November 09, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q3'26, revenue estimate is 245.47 million USD with EPS (earnings per share) anticipated at 0.37 USD. Learn more details at…